Monthly archive
- June 2009 (2)
- July 2009 (2)
- August 2009 (6)
- September 2009 (7)
- October 2009 (1)
- November 2009 (2)
- December 2009 (3)
- March 2010 (2)
- April 2010 (2)
- June 2010 (3)
Tags
Blogroll
Case Studies
An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...
For Reporters
For journalists and other media professionals
PIPC remains optimistic
PIPC remains optimistic that patient-centered comparative effectiveness research (CER) will be included in health reform legislation, despite its disappointment that the House Energy and Commerce Committee did not act on the bi-partisan patient-centered CER amendment during their work last week.
"We appreciate Committee members' work on this issue, and Chairman Waxman's commitment to working to include the amendment in the final House health reform bill," PIPC Chairman Tony Coelho said. "PIPC will continue to work in support of patient-centered CER as part of comprehensive health care reform."
The Christensen-Inslee-Upton-Walden amendment was based on legislation introduced by Rep. Kurt Schrader (D-OR) in the House (H.R. 2502) and Sens. Baucus and Conrad in the Senate (S. 1213).
"This approach to CER will ensure that the research is focused on the needs of patients, and is not used in ways that interfere with the treatment decisions made by doctors and their patients," Coelho said.